Cosmetic hormone ingredient analysis is a specialized laboratory testing service that detects illegal glucocorticoids, sex hormones, and other banned steroidal substances in skincare and personal care products. Using advanced LC-MS/MS and HPLC techniques aligned with GB, ISO, and EU regulatory standards, accredited third-party laboratories help manufacturers, brands, and regulators verify product safety and market compliance. This guide explains the testing scope, analytical methods, sample requirements, and practical applications of hormone screening for cosmetics.
Technical Overview
Hormones, including glucocorticoids (corticosteroids) and sex hormones such as estrogens, androgens, and progestogens, are strictly prohibited ingredients in cosmetics under most international regulations. China's Safety and Technical Standards for Cosmetics (2015) lists more than 1,300 prohibited components, including 41 glucocorticoids and multiple steroidal hormones, while EU Regulation (EC) No 1223/2009 similarly bans these substances in Annex II. Despite the prohibition, unscrupulous manufacturers may illegally add hormones to products because they deliver rapid, visible short-term effects such as skin brightening, anti-inflammatory relief, and apparent improvement of acne or sensitive skin conditions.
Long-term use of hormone-contaminated cosmetics can cause serious adverse health effects, including hormone-dependent dermatitis, skin atrophy and thinning, telangiectasia (visible capillary dilation), rebound hyperpigmentation, pigmentation disorders, and systemic endocrine disruption in vulnerable populations such as infants and pregnant women. Cosmetic hormone ingredient analysis therefore serves as a critical control point for regulatory compliance, brand protection, and consumer safety assurance.
Accredited third-party laboratories perform this analysis using high-sensitivity instrumental methods, primarily liquid chromatography-tandem mass spectrometry (LC-MS/MS), supported by high-performance liquid chromatography (HPLC) and rapid immunoassay screening. Testing laboratories operate under quality management frameworks conforming to ISO/IEC 17025 to ensure technically valid, defensible results.
Testing Samples
Hormone testing applies to virtually all leave-on and rinse-off cosmetic categories. The most frequently submitted sample types include the following:
Facial Masks and Sheet Masks
Sheet masks and sleeping masks are the product category with the highest historical rate of glucocorticoid violations in market surveillance programs. The high-permeability formulas and occlusive application create rapid visible effects when hormones are illegally added, making this category a priority for screening.
Creams, Lotions, and Emulsions
Whitening creams, anti-aging creams, eczema-relief creams, and baby lotions are routinely tested. Emollient-rich oil-in-water and water-in-oil matrices require thorough extraction to release lipophilic steroid compounds for accurate quantification.
Serums, Essences, and Oils
Concentrated serums marketed for brightening, spot-fading, or soothing claims are analyzed for both glucocorticoids and sex hormones. Essential-oil-based and anhydrous products may require solvent adjustment to ensure complete extraction of steroidal residues.
Cleansers, Toners, and Wash-Off Products
Facial cleansers, makeup removers, and toners are tested to confirm compliance across full product lines, even though shorter skin contact reduces risk. Rinse-off products with anti-acne or soothing claims warrant particular attention.
Special Care and Baby Products
Products intended for infants, children, and sensitive-skin populations are subjected to the most stringent screening because endocrine-active substances pose elevated risks to these groups.
Testing Items
Testing panels are structured around regulatory prohibited-substance lists and typically fall into two major groups: glucocorticoids and sex hormones.
Glucocorticoids (Corticosteroids)
The core panel covers the 41 glucocorticoids prohibited under Chinese cosmetics regulations, with the most commonly detected compounds including:
- Hydrocortisone and hydrocortisone acetate
- Prednisone, prednisolone, and prednisolone acetate
- Dexamethasone and dexamethasone acetate
- Betamethasone, betamethasone valerate, and betamethasone dipropionate
- Triamcinolone acetonide
- Budesonide
- Fluocinolone acetonide and fluocinonide
- Clobetasol propionate
- Mometasone furoate
- Beclomethasone dipropionate
- Flumethasone pivalate and halometasone
- Desonide and 6-alpha-methylprednisolone
Sex Hormones and Endocrine-Active Substances
Screens cover estrogens, androgens, progestogens, and related synthetic compounds frequently targeted in regulations:
- Estrogens: estradiol, estrone, estriol, ethinylestradiol
- Synthetic estrogens: diethylstilbestrol, hexestrol, dienestrol
- Androgens and anabolic steroids: testosterone, methyltestosterone, nandrolone and its esters
- Progestogens: progesterone, medroxyprogesterone acetate, norethisterone, norgestrel
Reporting Basis
Because hormones are prohibited substances, results are reported against a "not detected" criterion rather than a permissible limit. Any confirmed detection above the method's limit of quantification constitutes non-compliance for regulatory purposes.
Testing Methods
Analysis follows a workflow of extraction, cleanup, instrumental determination, and confirmation, with methods validated for each cosmetic matrix type.
Sample Preparation
A typical procedure weighs 0.2 to 1.0 g of homogenized sample, extracts hormones with acetonitrile or methanol by vortexing and ultrasonication for 10 to 30 minutes, and centrifuges to remove matrix solids. Extracts may undergo solid-phase extraction (SPE) cleanup using C18 cartridges for emulsion- and oil-rich matrices, followed by filtration through a 0.22-micrometer membrane before injection.
LC-MS/MS Confirmatory Analysis
Liquid chromatography-tandem mass spectrometry is the primary confirmatory technique. Reversed-phase chromatographic separation is coupled with electrospray ionization and multiple reaction monitoring (MRM), typically with two characteristic ion transitions per analyte for identification. Isotope-labeled internal standards compensate for matrix effects and improve quantitative accuracy. Method detection limits generally reach the range of 0.1 to 10 micrograms per kilogram (ppb level), sufficient to identify both deliberate illegal addition and trace cross-contamination.
HPLC Screening
High-performance liquid chromatography with diode-array or ultraviolet detection, consistent with the GB/T 24800.2-2009 method for the determination of glucocorticoids in cosmetics, remains an effective screening and semi-quantitative tool. Presumptive positives identified by HPLC are confirmed by LC-MS/MS.
Rapid Immunoassay Screening
Method Validation and Quality Control
Validated methods demonstrate recoveries typically between 70% and 120%, precision with relative standard deviations below 15%, matrix-matched calibration, and procedural blanks with every analytical batch. Identification criteria follow internationally accepted retention-time and ion-ratio tolerances to ensure legally defensible reporting.
Applications
Hormone ingredient analysis supports multiple compliance and quality objectives across the cosmetics supply chain:
- Regulatory compliance verification against the Safety and Technical Standards for Cosmetics (2015), EU Regulation (EC) No 1223/2009, and equivalent requirements in markets such as Japan and ASEAN member states
- Pre-market testing for product registration, filing, and notification submissions to regulatory authorities
- Market surveillance and post-market sampling programs conducted by government inspectors
- Manufacturer quality control, raw material supplier verification, and batch release testing under ISO 22716 good manufacturing practice frameworks
- Import and export compliance, including documentation for customs and international buyers
- E-commerce platform product safety verification and seller due diligence
- Investigation of consumer complaints and adverse reaction cases
- Research and development support for reformulation and claim substantiation
FAQ
Why are hormones illegally added to cosmetics?
Glucocorticoids produce rapid anti-inflammatory, skin-brightening, and acne-suppressing effects, while some hormones create a quick perception of improved skin condition. These short-term benefits drive illegal addition, but discontinuation triggers rebound symptoms and long-term use causes skin damage, which is precisely why the substances are banned worldwide.
Which product categories carry the highest risk?
Facial masks, whitening and spot-fading creams, anti-acne products, eczema-relief or "medical-grade" skincare items, and baby care products show the highest violation frequency in historical surveillance data and should be prioritized for testing.
What regulations prohibit hormones in cosmetics?
China's Safety and Technical Standards for Cosmetics (2015) prohibits 41 glucocorticoids and multiple sex hormones. EU Regulation (EC) No 1223/2009 Annex II prohibits steroidal hormones in cosmetics, and comparable bans exist in major markets including Japan and ASEAN countries. Because these are prohibited substances, there is no permitted residue threshold.
What detection limits can be achieved?
Using LC-MS/MS, accredited third-party laboratories routinely achieve detection limits in the low parts-per-billion range, typically 0.1 to 10 micrograms per kilogram depending on the analyte and matrix, which reliably identifies both deliberate adulteration and trace-level contamination.
How much sample is required and how long does testing take?
A minimum of 5 to 10 grams, or one full retail unit, is generally sufficient for a complete hormone panel with retained backup. Standard turnaround is typically 5 to 10 working days after sample receipt, with expedited services available for urgent compliance deadlines.
How are results reported and interpreted?
Laboratories issue formal test reports listing each analyte, the method used, the limit of quantification, and the detected concentration or "not detected" status. Any confirmed detection of a prohibited hormone constitutes non-compliance, requiring investigation of raw materials, production lines, and packaging to identify the contamination source.
Why Choose ZKGX?
- State-of-the-art analytical equipment
- Highly qualified scientific team
- Fast turnaround time
- Competitive pricing